Seelos Therapeutics, Inc. (SEEL) Social Stream
SEELOS THERAPEUTICS INC (SEEL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SEEL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 6 | $14 | $6 | $9.5 | $1.45 | 555.17% |
| 2022-01-21 | 5 | $14 | $5 | $7.8 | $1.45 | 437.93% |
| 2022-03-08 | 5 | $14 | $3 | $7.4 | $1.45 | 410.34% |
| 2022-03-11 | 3 | $8 | $3 | $5.25 | $1.45 | 262.07% |
| 2022-06-16 | 4 | $8 | $3 | $5.25 | $1.45 | 262.07% |
| 2022-11-17 | 2 | $6 | $3 | $4.5 | $1.45 | 210.34% |
| 2022-12-14 | 3 | $6 | $3 | $4.333 | $1.45 | 198.83% |
| 2023-03-30 | 1 | $4 | $3 | $3.5 | $1.45 | 141.38% |
| 2023-05-15 | 4 | $4 | $4 | $4 | $1.45 | 175.86% |
| 2023-05-16 | 2 | $4 | $2 | $3.333 | $1.45 | 129.86% |
| 2023-08-15 | 3 | $4 | $2 | $3.333 | $1.45 | 129.86% |
| 2023-09-21 | 3 | $120.12 | $30.03 | $75.075 | $1.45 | 5077.59% |
The Trend in the Analyst Price Target
Over the past 15 months, SEEL's average price target has gone down $1.83.
SEEL reports an average of 5,290.07% for its upside potential over the past 26 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 1 | 4.00 | 3.00 | 3.500 | 0.692 | 405.78% |
| 2023-05-16 | 2 | 4.00 | 2.00 | 3.000 | 0.918 | 226.8% |
| 2023-05-16 | 1 | 4.00 | 2.00 | 3.000 | 0.918 | 226.8% |
| 2023-07-11 | 3 | 4.00 | 2.00 | 3.333 | 1.270 | 162.44% |
| 2023-09-21 | 3 | 120.12 | 30.03 | 75.075 | 0.190 | 39413.16% |
SEEL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
SEEL's average broker recommendation rating worsened by 1 over the prior 22 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SEEL as an investment opportunity.
- In the context of all US stocks, SEELOS THERAPEUTICS INC's average analyst price target is higher than 128.48% of them.
- In terms of how SEELOS THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 181.52% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, SEELOS THERAPEUTICS INC's variance in analysts' estimates is lower than -1098.95% of them.
- SEELOS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1196.06% of stocks in the small market cap category.
Stocks similar to SEELOS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CASI, GERN, and GOVX.
View All Top Stocks by Price Target
What is the outlook for SEEL? Use POWR Ratings for clearer insight into price direction.